GSE53960: rat RNA-Seq transcriptomic Bodymap
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Tfdp1 | rn6_v1_chr16_+_81089292_81089308 | 0.67 | 1.4e-43 | Click! |
Egr2 | rn6_v1_chr20_-_22459025_22459025 | 0.36 | 5.8e-11 | Click! |
Wt1 | rn6_v1_chr3_+_95133713_95133713 | 0.17 | 2.0e-03 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr11_+_86512797 Show fit | 118.15 |
ENSRNOT00000051680
|
glycoprotein Ib platelet beta subunit |
|
chr6_+_44009872 Show fit | 99.64 |
ENSRNOT00000082657
|
membrane bound O-acyltransferase domain containing 2 |
|
chr14_+_87312203 Show fit | 88.94 |
ENSRNOT00000088032
|
adenylate cyclase 1 |
|
chr8_+_118333706 Show fit | 87.64 |
ENSRNOT00000028278
|
chondroitin sulfate proteoglycan 5 |
|
chr1_-_72727112 Show fit | 86.16 |
ENSRNOT00000031172
|
BR serine/threonine kinase 1 |
|
chr7_-_116607408 Show fit | 83.07 |
ENSRNOT00000076009
ENSRNOT00000056554 |
lymphocyte antigen 6 complex, locus H |
|
chr17_-_78962476 Show fit | 77.41 |
ENSRNOT00000030228
|
N-myristoyltransferase 2 |
|
chr19_+_52086325 Show fit | 75.91 |
ENSRNOT00000020341
|
N-terminal EF-hand calcium binding protein 2 |
|
chr10_-_56444847 Show fit | 73.71 |
ENSRNOT00000056872
ENSRNOT00000092662 |
neuroligin 2 |
|
chr10_+_13854339 Show fit | 73.44 |
ENSRNOT00000004486
ENSRNOT00000043951 |
CASK interacting protein 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.0 | 322.0 | GO:0007269 | neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
8.6 | 248.2 | GO:1903831 | acetylcholine receptor signaling pathway(GO:0095500) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
6.2 | 240.4 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
3.9 | 223.1 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
4.8 | 177.6 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
4.1 | 156.4 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
1.7 | 147.3 | GO:0006334 | nucleosome assembly(GO:0006334) |
1.4 | 143.5 | GO:0071804 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
8.4 | 142.1 | GO:0005513 | detection of calcium ion(GO:0005513) |
4.7 | 137.6 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 699.7 | GO:0016021 | integral component of membrane(GO:0016021) |
3.6 | 636.1 | GO:0008021 | synaptic vesicle(GO:0008021) |
3.6 | 536.7 | GO:0045211 | postsynaptic membrane(GO:0045211) |
5.3 | 438.4 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
9.1 | 401.9 | GO:0048786 | presynaptic active zone(GO:0048786) |
8.0 | 357.9 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
3.1 | 289.9 | GO:0098793 | presynapse(GO:0098793) |
4.7 | 289.3 | GO:0043198 | dendritic shaft(GO:0043198) |
16.3 | 261.3 | GO:0031045 | dense core granule(GO:0031045) |
0.4 | 241.2 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 614.9 | GO:0005509 | calcium ion binding(GO:0005509) |
3.9 | 498.3 | GO:0044325 | ion channel binding(GO:0044325) |
1.9 | 436.1 | GO:0008017 | microtubule binding(GO:0008017) |
5.6 | 337.9 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
1.4 | 283.9 | GO:0005096 | GTPase activator activity(GO:0005096) |
4.5 | 257.0 | GO:0019894 | kinesin binding(GO:0019894) |
6.9 | 205.5 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
11.8 | 164.7 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
6.3 | 162.7 | GO:0016917 | GABA-A receptor activity(GO:0004890) GABA receptor activity(GO:0016917) |
1.8 | 161.6 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.5 | 373.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
1.6 | 288.1 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
5.1 | 212.1 | PID REELIN PATHWAY | Reelin signaling pathway |
3.7 | 183.1 | PID EPHB FWD PATHWAY | EPHB forward signaling |
7.7 | 161.2 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.5 | 148.9 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
2.2 | 145.9 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
4.6 | 129.5 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
2.6 | 125.8 | NABA COLLAGENS | Genes encoding collagen proteins |
3.4 | 119.6 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.6 | 445.4 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
22.8 | 342.1 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
5.6 | 219.3 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
8.7 | 218.1 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
11.1 | 199.9 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
5.7 | 183.6 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
12.2 | 182.9 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
10.6 | 158.8 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
2.0 | 157.6 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
5.0 | 155.8 | REACTOME KINESINS | Genes involved in Kinesins |